Brief: Dishman Carbogen Amcis Gets EIR From U.S. FDA For Bavla Facility
29/01/2019 06:04
Jan 29 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS :
* SAYS CO RECEIVED ESTABLISHMENT INSPECTION REPORT FROM US
FDA FOR
BAVLA FACILITY
* SAYS BAVLA FACILITY CONTINUES TO BE APPROVED BY US FDA
Source text - http://bit.ly/2Un5YeQ
Further company coverage: DSHM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dishman Carbogen Amcis
See all newsBrief: Dishman Carbogen Amcis Approves Raising Of Funds Via NCDs Worth Up To 380 Million Rupees
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis